Takeda Pharmaceutical Company Limited Reclassification Adjustments On Cash Flow Hedges Before Tax
Takeda Pharmaceutical Company Limited (TAK) reported Reclassification Adjustments On Cash Flow Hedges Before Tax of JPY 6.45 billion for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Notes › Derivative Instruments and Hedging Activities
ifrs-full:ReclassificationAdjustmentsOnCashFlowHedgesBeforeTax · last filed 2025-06-25
| Period end | Reclassification Adjustments On Cash Flow Hedges Before Tax 12 month |
|---|---|
| 2025-03-31 | 6.45B JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | 137.26B JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | 87.34B JPY 20-F · filed 2025-06-25 |
| 2022-03-31 | 79.32B JPY 20-F · filed 2024-06-26 |
| 2021-03-31 | 24.48B JPY 20-F · filed 2023-06-28 |
| 2020-03-31 | -620.00M JPY 20-F · filed 2022-06-29 |
| 2019-03-31 | 6.36B JPY 20-F · filed 2021-06-29 |
| 2018-03-31 | -4.24B JPY 20-F · filed 2020-06-24 |
| 2017-03-31 | 418.00M JPY 20-F · filed 2019-06-27 |